Overview

Cannabis and Polysubstance Use: Response Inhibition and Stress Exposure

Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase I non-therapeutic trial is to examine the neurological effects of cannabis on stress reactivity and inhibition in healthy cannabis and stimulant co-users. It is expected for high ratio CBD:THC cannabis oil to have the largest effect and low ratio CBD:THC cannabis oil to have a moderate effect on outcome measures compared to placebo.
Phase:
Phase 1
Details
Lead Sponsor:
University of British Columbia
Treatments:
Dronabinol